#MASCC
MASCC 2025 Highlights: Real-World Barriers to Olanzapine Use in Antiemetic Care for Highly Emetogenic Chemotherapy
@cancercaremascc.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC #Olanzapine #EmetogenicChemotherapy
Olanzapine Use in HEC: Insights from MASCC 2025
Olanzapine underused in HEC care—MASCC 2025 study reveals key factors influencing real-world prescribing.
oncodaily.com
June 28, 2025 at 9:34 PM
MASCC 2025 Highlights: Advancing Cachexia Care Through Hormonal and Non-Pharmacological Interventions in Cancer Supportive Treatment
@cancercaremascc.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC #Cachexia
Cachexia Care at MASCC 2025: Hormonal Strategies Explored
Cachexia research at MASCC 2025 highlights hormonal and non-pharmacological strategies to improve muscle mass, fatigue, and quality of life.
oncodaily.com
June 28, 2025 at 9:35 PM
November 25, 2024 at 3:22 PM
November 21, 2024 at 6:07 PM
MASCC 2025 Highlights: Gut Microbiota as a Novel Target for Managing Chemotherapy-Induced Neurological Toxicities
@cancercaremascc.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC2025 #GutMicrobiota
Gut Microbiota and Neurotoxicity in Cancer: MASCC 2025
MASCC 2025 explores gut microbiota as a new target for cancer-related neuropathy and cognitive impairment.
oncodaily.com
June 29, 2025 at 9:52 PM
In 2025, we welcome and congratulate our inaugural cohort of MASCC Fellows (FMASCC). Fellow status is awarded to individuals who have made a sustained contribution to MASCC and demonstrated a continued high level of excellence in cancer supportive care practice and/or research.

#MASCC25
June 26, 2025 at 7:17 PM
OncoAlert along with our partners at ESSO, ESGO, MASCC & SIOG Proudly Announce 1/3 of our faculty, more soon@

Register HERE
https://buff.ly/3CChgre

@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
@erikahamilton9.bsky.social
@agerikssonmd.bsky.social
November 19, 2024 at 4:11 PM
MASCC 2025 Highlights: Exploring Drug Repurposing to Target Neural-Tumor Interactions and Improve Supportive Cancer Care Outcomes
@cancercaremascc.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC
Drug Repurposing in Cancer Supportive Care: MASCC 2025
At MASCC 2025, Dr. Moran Amit highlights how drug repurposing targeting neural-tumor pathways can enhance cancer supportive care.
oncodaily.com
June 28, 2025 at 9:34 PM